HEIDELBERG, Germany (AP) — HEIDELBERG, Germany (AP) — Affimed N.V. (AFMD) on Tuesday reported a loss of $34.3 million in its first quarter.
On a per-share basis, the Heidelberg, Germany-based company said it had a loss of 23 cents.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 22 cents per share.
The drug developer posted revenue of $4.8 million in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $6.6 million.
The company’s shares closed at $1.07. A year ago, they were trading at $3.28.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AFMD at https://www.zacks.com/ap/AFMD
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
